Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 8-K Event Other events
  5. 4 Insider Changes in Ownership
  6. 8-K Event Regulation FD disclosure
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Regulation FD disclosure
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 4 Insider Changes in Ownership

Page 22 of 27 · 537 filings